CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-113 Cr | ₹-99 Cr | ₹-99 Cr | ₹-85 Cr | ₹-100 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-113 Cr |
| Mar2025 | ₹-99 Cr |
| Mar2024 | ₹-99 Cr |
| Mar2023 | ₹-85 Cr |
| Mar2022 | ₹-100 Cr |
How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-113 Cr | Negative | |
| Mar2025 | ₹-99 Cr | Negative | |
| Mar2024 | ₹-99 Cr | Negative | |
| Mar2023 | ₹-85 Cr | Negative | |
| Mar2022 | ₹-100 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹16,137.7 Cr | -2.1% | 23% | -8.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -2.1% |
23% |
-8.5% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses